RecruitingNCT06458374
ATTR Cardiac Amyloidosis in a Selected Population
Prevalence and Long Tem Follow Up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome
Sponsor
Helse Møre og Romsdal HF
Enrollment
180 participants
Start Date
Sep 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.
Eligibility
Min Age: 50 Years
Inclusion Criteria3
- Male \> 50 years
- Female \> 60 years
- operated CTS at Ålesund Hospital
Exclusion Criteria5
- not consented
- do not speak Norwegian
- secondary cause of CTS as traumatic or rheumatic
- cannot be followed \> 5 years due to other medical conditions
- Cardiac disease at time of operation for CTS
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06458374
Related Trials
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
NCT060344056 locations
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
NCT068360118 locations
NatiOnal Referral cenTEr Study of Transthyretin Amyloid Cardiomyopathy(ATTR) Patients on Tafamidis
NCT062517781 location
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
NCT063182601 location